Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?

Introduction: More than two billion people are latently infected with Mycobacterium tuberculosis. Most tuberculosis (TB)-subunit vaccines currently in various stages of clinical trials are designed for prevention of active TB, but not to prevent reactivation of latent TB-infection. Thus, there is an...

Full description

Bibliographic Details

Published in:	Expert Review of Vaccines
Main Authors:	Farzad Khademi, Mohammad Derakhshan, Arshid Yousefi-Avarvand, Mohsen Tafaghodi, Saman Soleimanpour
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2018-01-01
Subjects:	mycobacterium tuberculosis multistage vaccines bcg delivery systems/adjuvants
Online Access:	http://dx.doi.org/10.1080/14760584.2018.1406309